Start with the end in mind: Meticulous planning of CMC activities is a cornerstone of success to launch complex biological molecules.

In her conference presentation at the Festival of Biologics (15 Oct 2024, Basel, Switzerland), Evelyn Sollner overviews our set-up for successful strategic planning of late-stage CMC activities.

You'll learn:

  • How Lonza, as a trusted CDMO partner, can support you at every step of the journey, from lab-scale development to BLA approval.
  • Our tailored 5-step approach for the planning of CMC activities towards BLA filing, with a focus on process characterization.
  • How we design activities in alignment with your product, process, timeline, and risk tolerance to ensure a smooth and efficient path to market.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.
Latest briefing from the Knowledge Center